A PHASE-II STUDY OF THE ADMINISTRATION OF RECOMBINANT INTERLEUKIN-2 (RIL-2) PLUS LYMPHOKINE ACTIVATED KILLER (LAK) CELLS IN STAGE-IV MELANOMA PATIENTS

被引：12

作者：

CASCINELLI, N

BELLI, F

MARCHINI, S

MAROLDA, R

PRADA, A

SCIORELLI, G

VILLANI, F

GAMBACORTIPASSERINI, C

GALAZKA, A

PARMIANI, G

机构：

[1] IST NAZL TUMORI,DIV EXPTL ONCOL D,I-20133 MILAN,ITALY

[2] GLAXO INST MOLEC BIOL,GENEVA,SWITZERLAND

[3] IST NAZL TUMORI,DIV THORAC SURG,I-20133 MILAN,ITALY

[4] IST NAZL TUMORI,DIV ANESTHESIOL,I-20133 MILAN,ITALY

[5] IST NAZL TUMORI,DIV IMMUNOHEMATOL,I-20133 MILAN,ITALY

[6] IST NAZL TUMORI,DIV CARDIOL,I-20133 MILAN,ITALY

来源：

TUMORI | 1989年 / 75卷 / 03期

关键词：

D O I：

10.1177/030089168907500309

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：233 / 244

页数：12

共 35 条

[1]

AGAH R, 1988, CANCER RES, V48, P2245

[2]

AMER MH, 1979, SURG GYNECOL OBSTET, V149, P687

[3]

BALSARI A, 1986, CANCER IMMUNOL IMMUN, V21, P148

[4] ALLOSTIMULATION OF PATIENTS LYMPHOCYTES GENERATES BOTH T-LIKE AND NK-LIKE CELLS CYTO-TOXIC FOR AUTOLOGOUS MELANOMA [J].

BALSARI, A ;

FOSSATI, G ;

TARAMELLI, D ;

TONA, G ;

DELIA, D ;

GIARDINI, R ;

PARMIANI, G .

BRITISH JOURNAL OF CANCER, 1985, 52 (01) :73-80

[5]

BARRETT MC, 1920, HEART, V7, P353

[6]

BELLI F, 1988, IL GIORNALE CHIRURGI, V9, P27

[7] PASSIVE ADOPTIVE IMMUNOTHERAPY OF LOW-IMMUNOGENIC BALB/C LYMPHOMA BY SYNGENEIC ALLOIMMUNE LYMPHOCYTES-T [J].

COLOMBO, MP ;

ARIOLI, I ;

PARMIANI, G .

INTERNATIONAL JOURNAL OF CANCER, 1984, 34 (06) :807-813

[8]

DAMLE NK, 1987, J IMMUNOL, V138, P1779

[9] MALIGNANT-MELANOMA PROGNOSTIC FACTORS-6 - DISTANT METASTASES AND LENGTH OF SURVIVAL [J].

DAY, CL ;

LEW, RA .

JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1984, 10 (09) :686-689

[10]

DINAKARA P, 1970, AM REV RESPIR DIS, V102, P962

← 1 2 3 4 →